| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
This week: Q1 earnings reveal a widening market divide, DEA nominee prioritizes rescheduling, and Rove and Swade make big expan...
GTI, Verano, Cannabist, MariMed, Cronos and IIPR reported Q1 2025 earnings. Here's what happened.
Viridian Capital's latest report shows cannabis stocks pricing in no rescheduling or 280E relief, leaving MSOs stuck in val...
Discover how cannabis for pain management reduced opioid prescriptions by 53% in Utah, signaling new opportunities for medical ...
Cannabis company Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) is launching the award-winning California-grown Claybourne...
Analysts have a range of choices when valuing cannabis companies. Viridian commonly uses Discounted Cash Flow Analysis, Public ...
Cannabist partners with COAST Cannabis to launch artisan chocolates and gummies in Maryland and New Jersey, expanding edibles m...